INDICATIONS

Mast Ext 200 is a slow released long acting treatment for breast cancer in elderly post menopausel women as part of a specific immunotherapy.

INGREDIENT

Drostalone Enanthate 200mg

PRESENTATION

Each vial contains 10ml (200mg/ml)